Abstract
The complex microbial community of the gastrointestinal tract (GIT) plays an important role in GIT health and in whole body wellbeing by aiding digestion, producing nutrients, protecting against pathogens and in the maturation of the host immune system. A balanced intestinal microbiota and balanced microbe-microbe-host relationships is essential for the performance of all physiological, biochemical and enzymatic machinery in the GIT. Dietary nutrients are converted into metabolites, such as short-chain fatty acids (SCFAs) by the GIT microbiota that serve as biologically active molecules with regulatory functions in the host. When the intestinal microbiota gets unbalanced (dysbiosis) changes to this population can have major consequences. Probiotics may restore the balance of the composition of the GIT microbiota. Prebiotics can modulate the GIT microbiota inducing the growth of probiotic bacteria and can additionally produce beneficial effects on the host. Although there has been a great advance on the knowledge on the composition of the human gut microbiota, still more studies are needed to clarify the interaction of the host and the microbiota, determine the factors that govern host colonization and understand the ecological role of the common and diverse resident microbiota of the human gut.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alberts B, Johnson A, Lewis J et al (2002) Molecular biology of the cell, 4th edn. Garland Science, New York
Alkhalil M, Tate S (2010) Does endocarditis require routine coagulation screening? BMJ Case Rep
Alpert C, Sczesny S, Gruhl B, Blaut M (2008) Long-term stability of the human gut microbiota in two different rat strains. Curr Issues Mol Biol 10(1–2):17–24
Aminov RI (2013) Role of archaea in human disease. Front Cell Infect Microbiol 3:42
Andersen LO, Bonde I, Nielsen HB, Stensvold CR (2015) A retrospective metagenomics approach to studying Blastocystis. FEMS Microbiol Ecol 91(7):fiv072. doi:10.1093/femsec/fiv072
Attaluri A, Jackson M, Valestin J, Rao SS (2010) Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS. Am J Gastroenterol 105:1407–1411. doi:10.1038/ajg.2009.655
Asano I, Umemura M, Fujii S, Hoshino H, Iino H (2004) Effects of mannooligosaccharides from coffee mannan on fecal microbiota and defecation in healthy volunteers. Food Sci Technol Res 10:93–97
Backhed F, Ley RE, Sonnenburg JL et al (2005) Host-bacterial mutualism in the human intestine. Science 307:1915–1920
Bailey R (2010) Intestinal microbiota and the pathogenesis of dysbacteriosis in broiler chickens. Doctoral thesis, University of East Anglia
Balcazar JL (2014) Bacteriophages as vehicles for antibiotic resistance genes in the environment. PLoS Pathog 10(7):e1004219
Barcenilla A, Pryde SE, Martin JC et al (2000) Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Env Microbial 66(4):1654–1661
Baron M (2009) A patented strain of Bacillus coagulans increased immune response to viral challenge. Postgrad Med 121(2):114–118
Benmechernene Z, Fernandez-No I, Kihal M et al (2013) Recent patents on bacteriocins: food and biomedical applications. Recent Pat DNA Gene Sequences 7(1):66–73
Bennett KW, Eley A (1993) Fusobacteria: new taxonomy and related diseases. J Med Microbiol 39(4):246–254
Berrilli F, Di Cave D, Cavallero S, D’Amelio S (2012) Interactions between parasites and microbial communities in the human gut. Front Cell Infect Microbiol 16(2):141
Borrel G, O’Toole PW, Harris HM et al (2013) Phylogenomic data support a seventh order of Methylotrophic methanogens and provide insights into the evolution of Methanogenesis. Genome Biol Evol 5(10):1769–1780. doi:10.1093/gbe/evt128
Bouchard JD, Moineau S (2000) Homologous recombination between a lactococcal bacteriophage and the chromosome of its host strain. Virology 270(65–75):7
Boyd EF, Brussow H (2002) Common themes among bacteriophageencoded virulence factors and diversity among the bacteriophages involved. Trends Microbiol 10:521–529
Brabban AD, Hite E, Callaway TR (2005) Evolution of foodborne pathogens via temperate bacteriophage-mediated gene transfer. Foodborne Pathog Dis 2:287–303
Brahe LK, Le Chatelier E, Prifti E et al. (2015) Specific gut microbiota features and metabolic markers in postmenopausal women with obesity. Nutrition & Diabetes. 5:e159. doi:10.1038/nutd.2015.9
Breitbart M, Haynes M, Kelley S et al (2008) Viral diversity and dynamics in an infant gut. Res Microbiol 159:367–373
Brestoff JR, Artis D (2013) Commensal bacteria at the interface of host metabolism and the immune system. Nat Immunol 14:676–684
Brown EM, Sadarangani M, Finlay BB (2013) The role of the immune system in governing host-microbe interactions in the intestine. Nat Immunol 14(7):660–667
Brussow H, Canchaya C, Hardt W-D (2004) Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68:560–602
Buelow E et al (2014) Effects of selective digestive decontamination (SDD) on the gut resistome. J Antimicrob Chemother 69:2215–2223
Calo-Mata P, Arlindo S, Boehme K et al (2008) Current applications and future trends of lactic acid bacteria and their bacteriocins for the biopreservation of aquatic food products. Food Bioprocess Technol 1(1):43–63
Canchaya C, Proux C, Fournous G et al (2003) Prophage genomics. Microbiol Mol Biol Rev 67:238–276
Casjens S (2003) Prophages and bacterial genomics: what have we learned so far? Mol Microbiol 49:277–300
Card RM, Warburton PJ, MacLaren N et al (2014) Application of microarray and functional-based screening methods for the detection of antimicrobial resistance genes in the microbiomes of healthy humans. PLoS ONE 9:e86428
Castellarin M, Warren RL, Freeman JD et al (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 22(2):299–306
Chen HL, Cheng HC, Wu WT et al (2008) Supplementation of konjac glucomannan into a low-fiber Chinese diet promoted bowel movement and improved colonic ecology in constipated adults: a placebo-controlled, diet-controlled trial. J Am Coll Nutr 27(1):102–108
Chibani-Chennoufi S, Bruttin A, Dillmann M-L, Brüssow H (2004) Phage-host interaction: an ecological perspective. J Bacteriol 186:3677–3686
Claesson MJ, Jeffery IB, Conde S et al (2012) Gut microbiota composition correlates with diet and health in the elderly. Nature 488(7410):178–184
Collins MD, Lawson PA, Willems A et al (1994) The phylogeny of genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 44:812–826
Conlon M Bird, AR (2014) The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7:17–44.
Cui L, Morris A, Ghedin E (2013) The human mycobiome in health and disease. Genome Med 5(7):63
Cuskin F, Lowe EC, Temple MJ et al (2015) Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature 517(7533):165–169
Cooke G, Behan J, Costello M (2006) Newly identified vitamin K-producing bacteria isolated from the neonatal faecal flora. Microb Ecol Health Dis 18(3–4):133–138
Dave M, Higgins PD, Middha S, Rioux KP (2012) The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 160(4):246–257
David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505:559–563
Davis BM, Waldor MK (2003) Filamentous phages linked to virulence of Vibrio cholerae. Curr Opin Microbiol 6:35–42
de Vrese M, Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. In: Food biotechnology. Springer, Berlin, pp 1–66
den Besten G, van Eunen K, Groen AK et al (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325–2340
Denoeud F, Roussel M, Noel B, Wawrzyniak I et al (2011) Genome sequence of the stramenopile Blastocystis, a human anaerobic parasite. Genome Biol 12(3):R29
Dethlefsen L, Huse S, Sogin ML, Relman DA (2008) The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 6(11):e280
Derrien M, Vaughan EE, Plugge CM, de Vos WM (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol 54(Pt 5):1469–1476
Desiere F, McShan WM, van Sinderen D, Ferretti JJ, Brussow H (2001) Comparative genomics reveals close genetic relationships between phages from dairy bacteria and pathogenic streptococci: evolutionary implications for prophage-host interactions. Virology 288:325–341
Dinleyici EC, Eren M, Ozen M et al (2012) Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin Biol Ther 12:395–410
Drasar BS (1991) The bacterial flora of the intestine. In: Rowland IR (ed). Role of the gut flora in toxicity and cancer, Chap. 2. Academic Press, New York, pp 23–38
Dridi B, Raoult D, Drancourt M (2011) Archaea as emerging organisms in complex human microbiomes. Anaerobe 17:56–63
Dubourg G, Lagier JC, Armougom F et al (2013) High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment. Int J Antimicrob Agents 41(2):149–155
Duncan SH, Hold GL, Barcenilla A et al (2002) Roseburia intestinalis sp. nov, a novel saccharolytic, butyrate-producing bacterium from human faeces. Int J Syst Evol Microbiol 52(5):1615–1620
Duncan SH, Belenguer A, Holtrop G et al (2007) Reduced dietary intake of carbohydrates by obese subjects results in decreased concentrations of butyrate and butyrate-producing bacteria in feces. Appl Environ Microbiol 73:1073–1078
Dutilh BE, Cassman N, McNair K et al (2014) A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat Commun 5:4498
Eckburg PB, Bik EM, Bernstein CN et al (2005) Diversity of the human intestinal microbial flora. Science 308:1635–1638
Eeckhaut V, Machiels K, Perrier C et al (2012) Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut, gutjnl-2012
Engen PA et al (2015) The gastrointestinal microbiome. Alcohol Res 37(2):223–236
Evans H, Mitre E (2015) Worms as therapeutic agents for allergy and asthma: understanding why benefits in animal studies have not translated into clinical success. J Allergy Clin Immunol 135:343–353
Farmer AD, Mohammed SD, Dukes GE et al (2014) Caecal pH is a biomarker of excessive colonic fermentation. World J Gastroenterol WJG 20(17):5000
Ferreira I et al (2013) Hookworm excretory/secretory products induce interleukin-4 (IL-4)+IL-10+CD4+T cell responses and suppress pathology in a mouse model of colitis. Infect Immun 81:2104–2111
Finkbeiner SR, Allred AF, Tarr PI et al (2008) Metagenomic analysis of human diarrhea: viral detection and discovery. PLoS Pathog 4:e1000011. doi:10.1371/journal.ppat.1000011
Finkbeiner SR, Le BM, Holtz LR et al (2009) Detection of newly described astrovirus MLB1 in stool samples from children. Emerg Infect Dis 15:441–444
Fletcher SM, Stark D, Harkness J, Ellisa J (2012) Enteric protozoa in the developed world: a public health perspective clin. Microbiol Rev 25(3):420–449
Focà A, Liberto MC, Quirino A et al (2015) Gut inflammation and immunity: what is the role of the human gut virome? Mediators Inflamm 2015:326032
Fukuda S, Toh H, Hase K, Oshima K et al (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469(7331):543–547
Frémont M, Coomans D, Massart S, De Meirleir K (2013) High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients. Anaerobe 22:50–56
Forslund K, Sunagawa S, Coelho LP, Bork P (2014) Metagenomic insights into the human gut resistome and the forces that shape it. BioEssays 36:316–329
Francino MP (2014) Early development of the gut microbiota immune health pathogens. Pathog 3(3):769–790
Fujimura KE, Slusher NA, Cabana MD, Lynch SV (2010) Role of the gut microbiota in defining human health. Expert Rev Anti Infect Ther 4:435–454
Furnari M, Savarino E, Bruzzone L et al (2012) Reassessment of the role of methane production between irritable bowel syndrome and functional constipation. J Gastrointest Liver Dis 21:157–163
Gabbard SL, Lacy BE, Levine GM, Crowell MD (2014) The impact of alcohol consumption and cholecystectomy on small intestinal bacterial overgrowth. Dig Dis Sci 59(3):638–644
Gaci N, Borrel G, Tottey W et al (2014) Archaea and the human gut: new beginning of an old story. World J Gastroenterol WJG 20(43):16062
Gaze S et al (2012) Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog 8:e1002520
Geirnaert A, Steyaert A, Eeckhaut V et al (2014) Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Anaerobe 30:70–74
Geirnaert A, Wang J, Tinck M et al (2015) Interindividual differences in response to treatment with butyrate-producing Butyricicoccus pullicaecorum 25–3T studied in an in vitro gut model. FEMS Microbiol Ecol 91(6):fiv054. doi:10.1093/femsec/fiv054
Gerritsen J, Smidt H, Rijkers GT, de Vos WM (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6(3):209–240
Giacomin PR, Moy RH, Noti M et al (2015). Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. J Exp Med 212:1513–1528
Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412
Gibson MK, Pesesky MW, Dantas G (2014) The yin and yang of bacterial resilience in the human gut microbiota. J Mol Biol 426(23):3866–3876
Gómez-Moreno R, Robledo IE, Baerga-Ortiz A (2014) Direct detection and quantification of bacterial genes associated with inflammation in dna isolated from stool. Adv Microbiol 4(15):1065–1075
Gosiewski T et al (2014) Quantitative evaluation of fungi of the genus Candida in the feces of adult patients with type 1 and 2 diabetes—a pilot study. Gut Pathog 6:43
Gouba N, Raoult D, Drancourt M (2013) Plant and fungal diversity in gut microbiota as revealed by molecular and culture investigations. PLoS ONE 8(3):e59474
Guinane CM, Cotter PD (2013) Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol 6(4):295–308
Gupta R, Prasad Y (2011) Efficacy of polyvalent bacteriophage p-27/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol 62:255–260
Hakansson A, Molin G (2011) Gut microbiota and inflammation. Nutr 3(6):637–682
Hayes KS, Bancroft AJ, Goldrick M et al (2010) Exploitation of the intestinal microbiota by the parasitic nematode Trichuris muris. Science 328:1391–1394
Hebestreit HF (2001) Proteomics: an holistic analysis of nature’s proteins. Curr Opin Pharmacol 1(5):513–520
Hehemann JH, Correc G, Barbeyron T et al (2010) Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 464:908–912
Hemarajata P, Versalovic J (2013) Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol 6(1):39–51
Hofer U (2013) Variation in the gut virome. Nat Rev Microbiol 11:596
Hoffmann C, Dollive S, Grunberg S et al (2013) Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE 17. 8(6):e66019
Hold GL, Pryde SE, Russell VJ et al (2002) Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 39(1):33–39
Holtz LR, Cao S, Zhao G et al (2014) Geographic variation in the eukaryotic virome of human diarrhea. Virology 468–470:556–564
Hosseini SV, Arlindo S, Böhme K et al (2009) Molecular and probiotic characterization of bacteriocin-producing Enterococcus faecium strains isolated from nonfermented animal foods. J Appl Microbiol 107(4):1392–1403
Hooper LV, Midtvedt T, Gordon JI (2002) How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 22:283–307
Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336:1268–1273
Horosheva TV, Vodyanoy V, Sorokulova I (2014) Efficacy of Bacillus probiotics in prevention of antibiotic-associated diarrhoea: a randomized, double-blind, placebo-controlled clinical trial. JMM Case Rep 1(3):e004036
Hu Y et al (2013) Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun 4:2151
Hugenholtz P, Goebel BM, Pace NR (1998) Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 180:4765–4774
Hullar MA, Fu BC (2014) Diet, the gut microbiome, and epigenetics. Cancer J (Sudbury Mass) 20(3):170
Hyman P, Abedon ST (2010) Bacteriophage host range and bacterial resistance. Adv Appl Microbiol 70:217–248
Inal J (2003) Phage therapy: a reappraisal of bacterio-phages as antibiotics. Arch Immunol Ther Exp 51:237–244
Jangi S, Lamont JT (2010) Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life. J Pediatr Gastroenterol Nutr 51:2–7
Jassim SAA, Limoges RG (2014) Natural solution to antibiotic resistance: bacteriophages ‘the living drugs’. World J Microbiol Biotechnol 30(8):2153–2170
Jeurink PV, van Bergenhenegouwen J, Jimenez E et al (2013) Human milk: a source of more life than we imagine. Benef Microbes 4:17–30
Kamada N, Chen GY, Inohara N, Núñez G (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14(7):685–690
Kau AL, Ahern PP, Griffin NW et al (2011) Human nutrition, the gut microbiome and the immune system. Nature 474(7351):327–336
Keen EC (2012) Phage therapy: concept to cure. Front Microbiol 3:238
Keithley J, Swanson B (2005) Glucomannan and obesity: a critical review. Altern Ther Health Med 11(6):30–34
Kelesidis T, Pothoulakis C (2012) Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Ther Adv Gastroenterol 5(2):111–125
Khosravi Y, Dieye Y, Poh BH, Ng CG, Loke MF, Goh KL, Vadivelu J (2014) Culturable bacterial microbiota of the stomach of Helicobacter pylori positive and negative gastric disease patients. Sci World J 2014:610421
Koren O et al (2011) Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci 108(Supplement 1):4592–4598
Kuitunen M, Saukkonen T, Ilonen J et al (2002) Intestinal permeability to mannitol and lactulose in children with type 1 diabetes with the HLA-DQB1 02 allele. Autoimmun 35(5):365–368, 42
Kurokawa K, Itoh T, Kuwahara T et al (2007) Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 14:169–181
Lawley TD, Clare S, Walker AW et al (2012) Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice. PLoS Pathog 8(10):e1002995
Lawley TD, Walker AW (2013) Intestinal colonization resistance. Immunol 138(1):1–11
Lawrence JG, Hendrix RW, Casjens S (2001) Where are the pseudogenes in bacterial genomes? Trends Microbiol 9:535–540
Lagier J, Armougom F, Million M et al (2012) Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect 18:1185–1193
Lee KM, Paik CN, Chung WC et al (2013) Breath methane positivity is more common and higher in patients with objectively proven delayed transit constipation. Eur J Gastroenterol Hepatol 25(6):726–732
Lee SC, San Tang M, Lim YA et al (2014) Helminth colonization is associated with increased diversity of the gut microbiota. PLoS Neglected Trop Dis 8:e2880. doi:10.1371/journal.pntd.0002880
Li Q, Wang C, Zhang Q et al (2012) Use of 18S ribosomal DNA polymerase chain reaction-denaturing gradient gel electrophoresis to study composition of fungal community in 2 patients with intestinal transplants. Hum Pathol 43:1273–1281
Li Q, Wang C, Tang C et al (2014) Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn’s disease. J Clin Gastroenterol 48(6):513
León-Cabrera S, Callejas BE, Ledesma-Soto Y et al (2014) Extraintestinal helminth infection reduces the development of colitis-associated tumorigenesis. Int J Biol Sci 10(9):948
Loc-Carrillo C, Abedon ST (2011) Pros and cons of phage therapy. Bacteriophage 1(2):111–114
Logan AC, Rao AV, Irani D (2003) Chronic fatigue syndrome: lactic acid bacteria may be of therapeutic value. Med Hypotheses 60(6):915–923
Lopez-Legarrea P, Fuller NR, Zulet MA et al (2014) The influence of Mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pac J Clin Nutr 23:360–368
Lozupone CA, Stombaugh JI, Gordon JI et al (2012) Diversity, stability and resilience of the human gut microbiota. Nature 489:220–230
Lowy I, Molrine DC, Leav BA et al (2010) Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 362:197–205
Lu TK, Koeris MS (2011) The next generation of bacteriophage therapy. Curr Opin Microbiol 14:524–531
Luan C, Xie L, Yang X et al (2015) Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas. Sci Rep 5:7980
Lynch MF, Tauxe RV, Hedberg CW (2009) The growing burden of foodborne outbreaks due to contaminated fresh produce: risks and opportunities. Epidemiol Infect 137:307–315
Mai V, Draganov PV (2009) Recent advances and remaining gaps in our knowledge of associations between gut microbiota and human health. World J Gastroenterol 15:81–85
Mattarelli P, Brandi G, Calabrese C et al (2014) Occurrence of Bifidobacteriaceae in human hypochlorhydria stomach. Microb Ecol Health Dis 25. doi:10.3402/mehd.v25.21379
Mann NH (2008) The potential of phages to prevent MRSA infections. Res Microbiol 159:400–405. doi:10.1016/j.resmic.2008.04.003
Macfarlane GT, Steed H, Macfarlane S (2008) Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics. J Appl Microbiol 104(2):305–344
Martin FPJ, Wang Y, Sprenger N, et al (2008) Probiotic modulation of symbiotic gut microbial–host metabolic interactions in a humanized microbiome mouse model. Mol Syst Biol 4(1)
McFarland LV (2010) Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 16:2202–2222
Mihajlovski A, Doré J, Levenez F et al (2010) Molecular evaluation of the human gut methanogenic archaeal microbiota reveals an age-associated increase of the diversity. Environ Microbiol Rep 2(2):272–280
Minot S, Sinha R, Chen J et al (2011) The human gut virome: inter-individual variation and dynamic response to diet. Genome Res 21(10):1616–1625
Minot S, Bryson A, Chehoud C et al (2013) Rapid evolution of the human gut virome. Proc Natl Acad Sci USA 110:12450–12455
Mirpuri J, Raetz M, Sturge CR et al (2014) Proteobacteria-specific IgA regulates maturation of the intestinal microbiota. Gut Microbes 5(1):28–39
Mishra PK, Palma M, Bleich D et al (2014) Systemic impact of intestinal helminth infections. Mucosal Immunol 7(4):753–762
Moreira LR, Filho EX (2008) An overview of mannan structure and mannan-degrading enzyme systems. Appl Microbiol Biotechnol 79(2):165–178
Morgan XC, Huttenhower C (2014) Metagenomic analytic techniques for studying the intestinal microbiome. Gastroenterology 6(6):1437–1448
Mortimer K, Brown A, Feary J et al (2006) Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am J Trop Med Hyg 75:914–920
Muniesa M, Colomer-Lluch M and Jofre J (2013) Could bacteriophages transfer antibiotic resistance genes from environmental bacteria to human-body associated bacterial populations? Mob Genet Elements 3:739–751
Nardone G, Compare D (2015) The human gastric microbiota: is it time to rethink the pathogenesis of stomach diseases? United Eur Gastroenterol J 3(3):255–260
Neu J, Rushing J (2011) Cesarean versus vaginal delivery: long term infant outcomes and the hygiene hypothesis. Clin Perinatol 38(2):321–331
Neu J (2013) The microbiome and its impact on disease in the preterm patient. Curr Pediatr Rep 1(4):215–221
Neish AS (2009) Microbes in gastrointestinal health and disease. Gastroenterology 136:65–80
Novik GI, Astapovich NI, Ryabaya NE (2007) Production of hydrolases by lactic acid bacteria and bifidobacteria and their antibiotic resistance. Appl Biochem Microbiol 43(2):164–172
O’Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688–693
Oever JT, Netea MG (2014) The bacteriome-mycobiome interaction and antifungal host defense. Eur J Immunol 44(11):3182–3191
Ogilvie LA, Jones BV (2015) The human gut virome: a multifaceted majority. Front Microbiol 6:918
Ott ST, Musfeldt M, Ullmann U et al (2004) Quantification of intestinal bacterial populations by real-time pcr with a universal primer set and minor groove binder probes: a global approach to the enteric flora. J Clin Microbiol 42(6):2566–2572
Ott SJ, Kühbacher T, Musfeldt M et al (2008) Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43(7):831–841
Paliy O, Agans R (2012) Application of phylogenetic microarrays to interrogation of human microbiota. FEMS Microbiol Ecol 79(1):2–11
Palmer C, Bik EM, Di Giulio DB et al (2007) Development of the human infant intestinal microbiota. PLoS Biol 5:e177
Parfrey LW et al (2011) Microbial eukaryotes in the human microbiome: ecology, evolution, and future directions. Front Microbiol 2:153
Parracho HM, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microbiota of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54(10):987–991
Pérez-Cobas AE, Artacho A, Knecht H et al (2013) Differential effects of antibiotic therapy on the structure and function of human gut microbiota. PLoS ONE 8:e80201
Petrikkos G, Skiada A, Lortholary O et al (2012) Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 54(suppl 1):S23–S34
Potrykus J, Mahaney B, White RL, Bearne SL (2007) Proteomic investigation of glucose metabolism in the butyrate-producing gut anaerobe Fusobacterium varium. Proteomics 7(11):1839–1853
Pryde SE, Duncan SH, Hold GL et al (2002) The microbiology of butyrate formation in the human colon. FEMS Microbiol Lett 217(2):133–139
Qin J, Li R, Raes J et al (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464:59–65
Qin J, Li Y, Cai Z et al (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490:55–60
Quigley EM (2010) Prebiotics and probiotics: modifying and mining the microbiota. Pharmacol Res 61:213–218
Rajilić-Stojanović M, Biagi E, Heilig HG et al (2011) Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141(5):1792–1801
Reddy A, Fried B (2009) An update on the use of helminths to treat Crohn’s and other autoimmune diseases. Parasitol Res 104(2):217–221
Reyes A, Semenkovich NP, Whiteson K et al (2012) Going viral: next-generation sequencing applied to phage populations in the human gut. Nat Rev Microbiol 10:607–617
Reynolds LA et al (2015) Cohabitation in the intestine: interactions among helminth. J Immunol 195(9):4059–66
Reuter G (2001) The Lactobacillus and Bifidobacterium microbiota of the human intestine: composition and succession. Curr Issues Intest Microbiol 2(2):43–53
Rodríguez MM, Perez D, Chaves FJ et al (2015) Obesity changes the human gut mycobiome. Sci Rep 5:14600
Romano-Keeler J, Weitkamp J-H (2015) Maternal influences on fetal microbial colonization and immune development. Pediatr Res 77:189–195
Rupa P, Mine Y (2012) Recent advances in the role of probiotics in human inflammation and gut health. J Agric Food Chem 60(34):8249–8256
Salazar N et al (2015) Exopolysaccharides produced by lactic acid bacteria and bifidobacteria as fermen substrates by the intestinal microbiota. Crit Rev Food Sci Nutr. doi:10.1080/10408398.2013.770728
Samsel A, Seneff S (2013) Glyphosate’s suppression of cytochrome P450 enzymes and amino acid biosynthesis by the gut microbiome: Pathways to modern diseases. Entropy 15(4):1416–1463
Scarpellini E, Ianiro G, Attilivv F et al (2015) The human gut microbiota and virome: Potential therapeutic implications. Dig Liver Dis. doi:10.1016/j.dld.2015.07.008
Schnoeller C, Rausch S, Pillai S et al (2008) A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 180:4265–4272
Scholz-Ahrens KE, Schrezenmeir J (2007) Inulin and oligofructose and mineral metabolism: the evidence from animal trials. J Nutr 137(11 Suppl):2513S–2523S
Scholz-Ahrens KE, Ade P, Marten B et al (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137(3 Suppl 2):838S–846S
Scott KP, Martin JC, Duncan SH, Flint HJ (2014) Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. FEMS Microbial Ecol 87(1):30–40
Sears CL (2005) A dynamic partnership: celebrating our gut flora. Anaerobe 11(5):247–251
Sokol H, Seksik P (2010) The intestinal microbiota in inflammatory bowel diseases: time to connect with the host. Curr Opin Gastroenterol 26:327–331
Stearns JC et al (2011) Bacterial biogeography of the human digestive tract. Sci Rep 1:170
Suttle CA, Chan AM (1994) Dynamics and distribution of cyanophages and their effect on marine Synechococcus spp. Appl Environ Microbiol 60:3167–3174
Takaishi H, Matsuki T, Nakazawa A et al (2008) Imbalance in intestinal microbiota constitution could be involved in the pathogenesis of inflammatory bowel disease. Int J Med Microbiol 298:463–472
Tannock GW (2001) Molecular assessment of intestinal microbiota. Am J Clin Nutr 73:410S–414S
The Human Microbiome Project Consortium (2012a) Structure, function and diversity of the healthy human microbiome. Nature 486:207–214
The Human Microbiome Project Consortium (2012b) A framework for human microbiome research. Nature 486:215–221
Torres MF, Uetanabaro AP, Costa AF et al (2000) Influence of bacteria from the duodenal microbiota of patients with symptomatic giardiasis on the pathogenicity of Giardia duodenalis in gnotoxenic mice. J Med Microbiol 49(3):209–215
Tsuji S, Kawai N, Tsujii M, Kawano S, Hori M (2003) Inflammation related promotion of gastrointestinal carcinogenesis-a perigenetic pathway. Aliment Pharmacol Ther 18(s1):82–89
Turnbaugh PJ, Hamady M, Yatsunenko T et al (2009) A core gut microbiome in obese and lean twins. Nature 457:480–484
Van Immerseel F, Ducatelle R, De Vos M et al (2010) Butyric acid-producing anaerobic bacteria as a novel probiotic treatment approach for inflammatory bowel disease. J Med Microbiol 59(2):141–143
Van Schaik W (2015) The human gut resistome. Phil Trans R Soc B 370:20140087
van Tongeren SP, Slaets JP, Harmsen HJM et al (2005) Fecal microbiota composition and frailty. Appl Environ Microbiol 71:6438–6442
Vanhoutvin SA, Troost FJ, Hamer HM, Lindsey PJ et al (2009) Butyrate-induced transcriptional changes in human colonic mucosa. PloS One 4:e6759
Walker AW, Martin JC, Scott P et al (2015) 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome 3:26
Waller AS, Yamada T, Kristensen DM et al (2014) Classification and quantification of bacteriophage taxa in human gut metagenomes. ISME J 8:1391–1402
Wan LYM, Chen ZJ, Shah NP, El-Nezami H (2015) Modulation of intestinal epithelial defense responses by probiotic bacteria. Critical reviews in food science and nutrition, 00–00
Wang M, Ahrné S, Jeppsson B, Molin G (2005) Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 54(2):219–231
Wang ZK, Yang YS, Stefka AT et al (2014) Fungal microbiota and digestive diseases. Aliment Pharmacol Ther 39(8):751–766
Wang WL, Xu SY, Ren ZG et al (2015) Application of metagenomics in the human gut microbiome. World J Gastroenterol 21(3):803–814
Waterbury JB, Valois FW (1993) Resistance to co-occurring phages enables marine Synechococcus communities to coexist with cyanophages abundant in seawater. Appl Environ Microbiol 59:3393–3399
Weaver CM (2005) Inulin, oligofructose and bone health: experimental approaches and mechanisms. Br J Nutr 93(Suppl 1):S99–S103
Wiggins BA, Alexander M (1985) Minimum bacterial density for bacteriophage replication: implications for significance of bacteriophages in natural ecosystems. Appl Environ Microbiol 49:19–23
Wilson ID, Nicholson JK (2015) The modulation of drug efficacy and toxicity by the gut microbiome. In: Metabonomics and gut microbiota in nutrition and disease. Springer, London, pp 323–341
Wu GD, Chen J, Hoffmann C, Bittinger K et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334:105–108
Yatsunenko T, Rey FE, Manary MJ et al (2012) Human gut microbiome viewed across age and geography. Nature 486:222–227
Yuan S, Cohen DB, Ravel J, Abdo Z, Forney LJ (2012) Evaluation of methods for the extraction and purification of DNA from the human microbiome. PLoS ONE 7:e33865. doi:10.1371/journal.pone.0033865
Zoetendal EG, Rajilic-Stojanovic M, de Vos WM (2008) High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 57(11):1605–1615
Zwolinska-Wcislo M, Budak A, Bogdal J et al (2001) Fungal colonization of gastric mucosa and its clinical relevance. Med Sci Monit 7:982–988
Acknowledgments
This work was funded by a research project from the Spanish Ministry of Economy and Competitiveness Project AGL2013-48244-R and by the European Regional Development Fund (ERDF) (2007–2013).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Calo-Mata, P., Ageitos, J.M., Böhme, K., Barros-Velázquez, J. (2016). Intestinal Microbiota: First Barrier Against Gut-Affecting Pathogens. In: Villa, T., Vinas, M. (eds) New Weapons to Control Bacterial Growth. Springer, Cham. https://doi.org/10.1007/978-3-319-28368-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-28368-5_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-28366-1
Online ISBN: 978-3-319-28368-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)